| TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine I Kinde, E Munari, SF Faraj, RH Hruban, M Schoenberg, T Bivalacqua, ... Cancer research 73 (24), 7162-7167, 2013 | 275 | 2013 |
| Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ... European urology 69 (1), 157-165, 2016 | 255 | 2016 |
| 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ... Journal of Nuclear Medicine 56 (7), 1003-1010, 2015 | 231 | 2015 |
| Assessment of tumoral PD-L1 expression and intratumoral CD8+ T cells in urothelial carcinoma SF Faraj, E Munari, G Guner, J Taube, R Anders, J Hicks, A Meeker, ... Urology 85 (3), 703. e1-703. e6, 2015 | 170 | 2015 |
| Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate-and high-risk prostate cancer: early oncological outcomes from a randomized … JFP Lestingi, GB Guglielmetti, QD Trinh, RF Coelho, J Pontes Jr, ... European urology 79 (5), 595-604, 2021 | 141 | 2021 |
| Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis C Luchini, N Veronese, M Solmi, H Cho, JH Kim, A Chou, AJ Gill, SF Faraj, ... Oncotarget 6 (36), 39088, 2015 | 84 | 2015 |
| Clinicopathological and prognostic features of Epstein‐Barr virus infection, microsatellite instability, and PD‐L1 expression in gastric cancer MA Pereira, MFKP Ramos, SF Faraj, AR Dias, OK Yagi, B Zilberstein, ... Journal of surgical oncology 117 (5), 829-839, 2018 | 78 | 2018 |
| High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins X Zheng, J Zhuge, SM Bezerra, SF Faraj, E Munari, JT Fallon, XJ Yang, ... Journal of hematology & oncology 7, 1-5, 2014 | 73 | 2014 |
| Human papillomavirus infection and immunohistochemical p16INK4a expression as predictors of outcome in penile squamous cell carcinomas SM Bezerra, A Chaux, MW Ball, SF Faraj, E Munari, N Gonzalez-Roibon, ... Human pathology 46 (4), 532-540, 2015 | 55 | 2015 |
| Identification and validation of protein biomarkers of response to neoadjuvant platinum chemotherapy in muscle invasive urothelial carcinoma AS Baras, N Gandhi, E Munari, S Faraj, L Shultz, L Marchionni, ... PloS one 10 (7), e0131245, 2015 | 54 | 2015 |
| Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes NM Gandhi, A Baras, E Munari, S Faraj, LO Reis, JJ Liu, M Kates, ... Urologic Oncology: Seminars and Original Investigations 33 (5), 204. e1-204. e7, 2015 | 52 | 2015 |
| Gemcitabine and cisplatin neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma: Predicting response and assessing outcomes NM Gandhi, A Baras, E Munari, S Faraj, LO Reis, JJ Liu, M Kates, ... Urologic Oncology: Seminars and Original Investigations 33 (5), 204. e1-204. e7, 2015 | 52 | 2015 |
| Carnoy's solution is an adequate tissue fixative for routine surgical pathology, preserving cell morphology and molecular integrity MA Pereira, AR Dias, SF Faraj, CS Cirqueira, MT Tomitao, ... Histopathology 66 (3), 388-397, 2015 | 52 | 2015 |
| SPINK1 defines a molecular subtype of prostate cancer in men with more rapid progression in an at risk, natural history radical prostatectomy cohort MH Johnson, AE Ross, M Alshalalfa, N Erho, K Yousefi, S Glavaris, ... The Journal of urology 196 (5), 1436-1444, 2016 | 48 | 2016 |
| Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors N Gonzalez-Roibon, B Katz, A Chaux, R Sharma, E Munari, SF Faraj, ... Human pathology 44 (7), 1293-1299, 2013 | 48 | 2013 |
| Survival and prognosis of young adults with gastric cancer MCV Cormedi, MLH Katayama, RSC Guindalini, SF Faraj, ... Clinics 73, e651s, 2018 | 47 | 2018 |
| Pathological factors and prognosis of resected liver metastases of colorectal carcinoma: implications and proposal for a pathological reporting protocol GM Fonseca, P Herman, SF Faraj, JAP Kruger, FF Coelho, VB Jeismann, ... Histopathology 72 (3), 377-390, 2018 | 43 | 2018 |
| Prevalence of human papillomavirus types and variants and p16INK4a expression in head and neck squamous cells carcinomas in São Paulo, Brazil JC Betiol, L Sichero, HOO Costa, LL de Matos, MA Andreoli, S Ferreira, ... Infectious agents and cancer 11, 1-7, 2016 | 38 | 2016 |
| Prognostic significance of poorly differentiated clusters and tumor budding in colorectal liver metastases GM Fonseca, ES de Mello, SF Faraj, JAP Kruger, FF Coelho, ... Journal of surgical oncology 117 (7), 1364-1375, 2018 | 37 | 2018 |
| Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer PJ Hurley, D Sundi, B Shinder, BW Simons, RM Hughes, RM Miller, ... Clinical cancer research 22 (2), 448-458, 2016 | 37 | 2016 |
